藥物成份

共有 21702 個藥物成份

Scopolamine Hydrobromide (Hyoscine Hydrobromide) Content：99.0%~101.0% (anhydrous substance)

關聯藥證數量
1

Scopolamine N-Butylbromide contains not less than 98.0% and not more than 101.0% of C21H30BrNO4, calculated with reference to the dried substance.

關聯藥證數量
1

Secobarbital Enzyme, Polyclonal antibody reactive to secobarbital, NAD+,G6P

關聯藥證數量
1

Secukinumab

關聯藥證數量
1

Selegiline Hydrochloride contains 98.0%~101.0% of C13H18ClN, calculated on anhydrous substance.

關聯藥證數量
1

Selinexor

關聯藥證數量
1

Senkyu

關聯藥證數量
1

Sennosides 60% NLT 90.0% and NMT 110.0% of the labeled amount of sennosides The labeled amount is NLT 60.0% (w/w), calculated on the dried basis..

關聯藥證數量
1

Sennosides 80% (with maltodextrin)

關聯藥證數量
1

Sennosides contains not less than 90.0% and not more than 110.0% of C42H36O20Ca, calculated on the anhydrous basis.

關聯藥證數量
1

Sennosides contains not less than 90.0% and not more than 110.0% of the labeled amount of sennosides. The labeled amount is not less than 60.0%, calculated on the dried basis.

關聯藥證數量
1

Sensi-DiscTM brand discs are 6-mm discs prepared by impregnating high quality absorbent paper with accurately determined amounts of antibiotic or other chemotherapeutic agents. Discs are clearly marked on both sides with letters and numbers desig-nating the agent and the drug content.(See chart giving concentrations of reactive ingredients.)

關聯藥證數量
1

Sensi-DiscTM brand discs prepared by impregnating high quality absorbent paper with accurately determined amounts of antibiotic or other chemotherapeutic agents.Discs are clearly marked on both sides with letters and numbers designating the agent and the drug content. (See chart giving concentrations of reactive ingredients.)

關聯藥證數量
1

Sequestering agent

關聯藥證數量
1

Serratiopeptidase contains 2,000~2,600 Serratiopeptidase unit per mg.

關聯藥證數量
1

Serratiopeptidase contains not less than 1600 Serratiopeptidase Units and not more than 2600 Serratiopeptidase Units per mg.

關聯藥證數量
1

Serum separating gel: α-olefin-maleate ester oligomers.\nCoagulation accelerating membrane: Min-U-Sil and PVP, etc.\n

關聯藥證數量
1

Setraline Hydrochloride contains not less than 97.5% and not more than 102.0% of C17H18Cl3N, calculated on anhydrous substance.

關聯藥證數量
1

Sevelamer Carbonate contains Phosphate Binding Capacity 5.0-6.5 mmol/g of polymer (as dried basis)

關聯藥證數量
1

Sevelamer Hydrochloride contains Phosphate Binding Capacity 5.2-6.5 mmol/g of polymer (on dried basis)

關聯藥證數量
1

Seven specimens-LN 24-01 through LN 24-07

關聯藥證數量
1

Sheep anti-T4 coated microtiter wells, 96 wells.\nT4 Reference Standards: 0, 2, 5, 10, 15, and 25 ug/dl, 1set, 1.0 ml.\nEnzyme Conjugate Concentrate (11x), 1.3 ml.\nEnzyme Conjugate Diluent, 13 ml.\nTMB Reagent, 11 ml.\nStop Solution (1N HCl), 11 ml.

關聯藥證數量
1

Silde Ingredients: Cupric sulphate pentahydrate CuSO4 (5H2O) 1.7 mg (6.8 umol)

關聯藥證數量
1

Sildenafil Citrate contains not less than 98.0% and not more than 102.0% of C22H30N6O4S‧C6H8O7, calculated on anhydrous basis.

關聯藥證數量
1

Sildenafil Citrate Content：98.0 per cent to 102.0 per cent (anhydrous substance).

關聯藥證數量
1

Sildenafil Citrate contains 98.0%~102.0% of C22H30N6O4S．C6H8O7, calculated on the anhydrous and solvent-free basis.

關聯藥證數量
1

Sildenafil Citrate contains 98.0%~102.0% of C28H38N6O11S (anhydrous substance).

關聯藥證數量
1

Sildenafil Citrate contains NLT 98.0% and NMT 102.0% of sildenafil citrate (C22H30N6O4S．C6H8O7), calculated on the anhydrous and solvent-free basis.

關聯藥證數量
1

Sildenafil Citrate contains not less than 98.0 percent and not more than 102.0 percent of C28H38N6O11S, calculated on the anhydrous basis.

關聯藥證數量
1

Sildenafil Citrate contains not less than 98.0% and not more than 102.0% of C22H30N6O4S.C6H8O7, calculated on the dried basis.

關聯藥證數量
1

Sildenafil Citrate contains not less than 98.0% and not more than 102.0% of C22H30N6O4S.C6H8O7,calculated on the dried basis.

關聯藥證數量
1

Sildenafil Citrate contains not less than 98.0% and not more than 102.0% of C22H30N6O4S‧C6H8O7, calculated on anhydrous basis.

關聯藥證數量
1

Sildenafil Citrate contains not less than 98.0% and not more than 102.0% of C22H30N6O4S‧C6H8O7, calculated on the dried basis.

關聯藥證數量
1

Sildenafil Citrate contains not less than 98.0% and not more than 102.0% of C22H30N6O4S？C6H8O7, calculated with reference to the dried basis.

關聯藥證數量
1

Sildenafil Citrate contains not less than 98.0% and not more than 102.0% of C22H33N6O4S.C6H8O7 calculated on the anhydrous basis.

關聯藥證數量
1

Sildenafil Citrate contains not less than 98.0% and not more than 102.0% of C28H38N6O11S calculated on the dried substance.

關聯藥證數量
1

Sildenafil Citrate contains not less than 98.0% and not more than 102.0% of C28H38N6O11S, calculated on the anhydrous substance.

關聯藥證數量
1

Silica:suspended in biocide solution\nWasher Buffer 1:contains guanidine thiocyanate.\nWasher Buffer 2:contains organic buffer and biocide solution.\nWasher Buffer 3:contains inorganic buffer.\nElution Buffer:contains inorganic buffer.

關聯藥證數量
1

Silodosin contains NLT 98.0% and NMT 102.0% of Silodosin (C25H32F3N3O4), calculated on the dried basis.

關聯藥證數量
1

Silodosin contains not less than 98.0% and not more than 102.0% of C25H32F3N3O4, calculated on the anhydrous basis.

關聯藥證數量
1

Silodosin contains not less than 98.0%~102.0% of C25H32F3N3O4 (dried substance).

關聯藥證數量
1

Silver Sulfadiazine contains not less than 98.0 percent and not more than 102.0 percent of C10H9AgN4O2S, calculated on the dried basis.

關聯藥證數量
1

Silver Sulfadiazine contains not less than 98.0% and not more than 102% of C10H9AgN4O2S,calculated on the dried basis.

關聯藥證數量
1

Silver Sulfazine contains not less than 98.0% and not more than 102.0% of C10H9AgN4O2S, calculated on anhydrous substance.

關聯藥證數量
1

Silver sulphadiazine contains not less than 98% and not more than 102% of C10H9AgN4O2S,calculated on the dried basis.

關聯藥證數量
1

Silymarin contains not less than 68 percent,calculated on the dried basis.

關聯藥證數量
1

Silymarin contains not less than 70%,calculated on the dried basis.

關聯藥證數量
1

Silymarin contains not less than 90.0% and not more than 110.0% of C25H22O10；Mr482.4, expressed as silibinin, is within the range 30% m/m to 65% m/m (anhydrous extract).

關聯藥證數量
1

Silymarin exsiccated fructus cardui mariae extract containing 30%~65% of silymarin calculated as silybin.

關聯藥證數量
1

Silymarin(Milk Thistle Dry Extract) content not less than 90.0% and not more than 110.0% of the nominal content of silymarin, expressed as silibinin (C25H22O10；Mr 482.4), stated on the label. The nominal content of silymarin is within the range 52.5% m/m to 64.1% m/m (dried extract).

關聯藥證數量
1

Silymarin-mixture of the isomers silibinin, silicristin and silidianin:(C25H22O10) 1.Assay of Silymarin, determined as silibinin, per cent:From 30 to 65 2.Sum of silidianin and silicristin, per cent the total content of silymarin:From 20 to 45 3.Sum of silibianin A and silibianin B, per cent the total content of Silymarin:From 40 to 65 4.Sum of isosilibinin A and isosilibinin B, per cent the total content of silymarin:From 10 to 20

關聯藥證數量
1

Simethicone (Simeticone) content： 90.5 per cent to 99.0 per cent of poly(dimethyl-siloxane).

關聯藥證數量
1

Simethicone contains not less than 90.5% and not more than 99.0% of polydimethyl-siloxane([-(CH3)2SiO-]n), and not less than 4.0% and not more than 7.0% of silicon dioxide.

關聯藥證數量
1

Simethicone content: 90.5% - 99.0% of polydimethylsiloxane [-(CH3)2SiO-]n and 4.0% - 7.0% of silicon dioxide.

關聯藥證數量
1

Simethicone：Assay：90.5~99%

關聯藥證數量
1

Simeticone is a mixture of silicon dioxide and poly(dimethylsiloxane). The content of silica and poly(dimethylsiloxane) is 4%-7% and 90.5%-99.0%, respectively.

關聯藥證數量
1

Simmon citrate agar 24.2 g純水 1000 mL

關聯藥證數量
1

Simvastatin Assay(dry basis): 98.0-102.0%

關聯藥證數量
1

Simvastatin Content：98.0 per cent to 102.0 per cent (anhydrous substance) of C25H38O5

關聯藥證數量
1

Simvastatin contains not less than 97.0% and not more than 102.0% of C25H38O5, calculated on the dried substance.

關聯藥證數量
1

Simvastatin contains not less than 98.0 % and not more than 101.0 % of C25H38O5, calculated on the anhydrous basis.

關聯藥證數量
1

Simvastatin contains not less than 98.0% and not more than 101.0% of C25H38O5 calculated on dry basis.

關聯藥證數量
1

Simvastatin contains not less than 98.0% and not more than 101.0% of C25H38O5, calculated on the dried basis. It may contain a suitable antioxidant.

關聯藥證數量
1

Simvastatin contains not less than 98.0% and not more than 102.0% of C25H38O5, calculated on the dried basis.

關聯藥證數量
1

Single vial pool of equal amounts of red blood cells from two group O donors.There red blood cells have been prepared as a 2~4% suspension in a buffered preservative solution containing adenine and adenosine to retard hemolysis and/or loss of antigenicity during the dating period.

關聯藥證數量
1

Single vial pool of group O red blood cells. There red blood cells have been prepared as a 4-6% suspension in a buffered preservative solution containing adenosine and adenine to retard hemolysis during the dating period.

關聯藥證數量
1

Sitagliptin Phosphate (Monohydrate) contains not less than 99.0% and not more than 101.0% of C16H15F6N5O‧H3PO4‧H2O, calculated on anhydrous basis.

關聯藥證數量
1

Sitagliptin Phosphate Monohydrate Assay by HPLC (on anhydrous and solvent free basis): Not less than 98.0% w/w and not more than 102.0% w/w.

關聯藥證數量
1

Sitagliptin Phosphate Monohydrate contains not less than 98.0% and NMT 102.0% of C16H15F6N5O‧H3PO4‧H2O, calculated on the anhydrous substance.

關聯藥證數量
1

Sitagliptin Phosphate Monohydrate contains not less than 98.0% and not more than 102.0% of C16H15F6N5O‧H3PO4 on the anhydrous basis.

關聯藥證數量
1

Sitagliptin Phosphate Monohydrate contains not less than 98.0% and not more than 102.0% of C16H15F6N5O‧H3PO4‧H2O, calculated on the anhydrous substance.

關聯藥證數量
1

Sitagliptin Phosphate Monohydrate contains not less than 98.0% and not more than 102.0% of C16H18F6M5O5P, calculated on the anhydrous substance.

關聯藥證數量
1

Sitagliptin Phosphate Monohydrate contains not less than 98.0% w/w and not more than 102.0% w/w of C16H15F6N5O．H3PO4．H2O, calculated on the anhydrous basis.

關聯藥證數量
1

Sitagliptin Phosphate contains not less than 98.0% and not more than 102.0% of C16H15F6N5O‧H3PO4‧H2O calculated on the anhydrous and solvent-free substance.

關聯藥證數量
1

Sitagliptin Phosphate contents not less than 98.0% and not more than 102.0% of C16H18F6N5P‧H2O, calculated on the anhydrous substance.

關聯藥證數量
1

Sitagliptin Phosphate monohydrate contains not less than 98.0% and not more than 102.0% of C16H15F6N5O‧H3PO4‧H2O, calculated on the anhydrous and solvent-free basis.

關聯藥證數量
1

Sitagliptin phosphate contents not less than 98.0% and not more than 102.0% of C16H15F6N5O．H3PO4, calculated on the anhydrous basis.

關聯藥證數量
1

Sitagliptin phosphate monohydrate

關聯藥證數量
1

Slide Constituents：\np-hydroxy benzoyl choline iodide 0.049 mg(0.14μ mol)\nDially imidazole lueco dye 0.048 mg(0.10μ mol)

關聯藥證數量
1

Slide Ingredients: bromophenol blue 0.025mg (0.037 umol)

關聯藥證數量
1

Slide Ingredients: cholesterol oxidase (from Streptomyces ray fungus) 0.6 IU diarylimidazole leuco dye 0.135 mg (0.268 μmol) Other Ingredients: lipoprotein lipase, cholesterol esterase, peroxidase, ascorbate oxidase.

關聯藥證數量
1

Slide Ingredients:\nL - γ - glutamyl - p -nitroanilide 0.078 mg (0.29 μmol)\nOther Ingredients:\nglycylglycine.

關聯藥證數量
1

Slide Ingredients:\nL-alanine 0.485 mg(5.4 μmol)\nDiarylimidazole leuco dye 0.044 mg(0.0901 μmol)\nOther Ingredient:\n2 sodium α-ketoglutarate, potassium phosphate, pyruvate oxidase, peroxidase, ascorbate oxidase.\n

關聯藥證數量
1

Slide Ingredients:\nLipoprotein lipase (origin: Microorgranism) 0.40 U\ndiarylimidazole leuco olye 0.034mg (0.038 μmol)\nOther Ingredients:\nATP\nGlycerol kinase\nMagensium sulfate\nGlycerol-3-phosphate-oxidase\nPeroxidase\nAscorbate oxidase

關聯藥證數量
1

Slide Ingredients:\nLithium lactate 0.167 mg (1.8 μmol)\nnitrotetrazolium blue 0.124 mg (0.15 μmol)\nOther Ingredients:\nNAD+, Diaphorase, Ascorbate oxidase.

關聯藥證數量
1

Slide Ingredients:\ncreatine phosphate 2Na 0.268mg (1.2 μ mol)、\nNitrotetrazorium blue 0.122mg (0.15 μ mol)、\nOther Ingredient:\nADP, Glucose, Hexokinase, Glucose-6-phosphate dehydrogenase(G6PD), NAD+, Diaphorase\n\n

關聯藥證數量
1

Slide ingredient: Uricase (from: Candia utilis) 90mU Diarylimidazole leuco dye 0.05 mg (0.11μmol)\nOther ingredient: Peroxidase, Ascorbate oxidase.

關聯藥證數量
1

Slides：\nglucose oxidase (origin：black mold Aspergillus niger) 1.3U\n1,7-Dihydroxynaphthalene 0.031mg(0.19μmol)\n4-aminoantipyrine 0.11mg\nOther ungredient：\nPeroxidase

關聯藥證數量
1

Sod.Carboxymethylcellulose

關聯藥證數量
1

Sodium 150 mmol/L、Potassium 4.0 mmol/L、Chloride 6.2 mmol/L 、BUN 80mg/dL、Urea 171 mg/dL、Glucose 200mg/dL、Calcium 5.0mg/dL、Creatinine 1.0mg/dL、Phosporous 7.5mg/dL

關聯藥證數量
1

Sodium Acetate Trihydrate (分子量136.08) contains not less than 99.5% and not more than 101.0% of C2H3NaO2‧3H2O

關聯藥證數量
1

Sodium Acetate Trihydrate <0.2% Potassium Bicarbonate <0.3% Saponin <0.03% Preservatives <0.5% Nuclear Stain <0.003%

關聯藥證數量
1

Sodium Acetate Trihydrate contains not less than 99.5% and not more than 101.0% of C2H2NaO2•3H2O, calculated on the dried substance.

關聯藥證數量
1

Sodium Alginate Assay:90.8%~106%

關聯藥證數量
1

Sodium Ascorbate contains not less than 99.0% and not more than 101.0% of C6H7NaO6, calculated on the dried basis.

關聯藥證數量
1

Sodium Azide less than 0.1%; Uric acid 0.2mg/mL

關聯藥證數量
1

Sodium Azulene Sulfonate (Azulene Water Soluble) contains not less than 98.5% and not more than 101.5% of C15H17NaO3S．1/2H2O, calculated on the drying.

關聯藥證數量
1

Sodium Benzoate 347 mmol/LCaffeine 173.9 mmol/LSlfanilic acid 27 mmol/LHCL 50 mmol/LSodium Nitrite 0.36 mmol/LSodium Acetate 609 mmol/L

關聯藥證數量
1

Sodium Bicarbonate contains not less than 99.0% and not more than 100.5% of NaHCO3, calculated on the dried basis.

關聯藥證數量
1

Sodium Bicarbonate contains not less than 99.5% and not more than 100.5% of NaHCO3, calculated on the dried basis.

關聯藥證數量
1